Home Life Science Seattle-Based Pharma Co. Awarded $74MM DOD Contract for Drug Production
Life Science

Seattle-Based Pharma Co. Awarded $74MM DOD Contract for Drug Production

Share
Share
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announ
Thank you for your interest in The Registry. You must Subscribe or Log In to read the rest of this content.
Share

2026 Pacific Northwest CRE Rising Stars

PNW CRE Rising Stars

Featured Posts


Recent Posts

Related Articles

Alexandria’s 701 Dexter Crosses Toward Stabilization As Seattle Lab Demand Reawakens

Lake Union flagship anchors Alexandria’s bet on the region’s institutional research baseThank...

U.S. Life Sciences Vacancy Tops 70% of New Deliveries as 60MM SQFT Pipeline Reshapes Market

Savills says supply surge from pandemic-era development boom is outpacing demand, leaving...

Social Media Auto Publish Powered By : XYZScripts.com

Create a free account, or log in.

Gain access to read this article, plus limited free content.

Yes! I would like to receive new content and updates.